19
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Contribution of the astrocytic tau pathology to synapse loss in progressive supranuclear palsy and corticobasal degeneration

      research-article

      Read this article at

      ScienceOpenPublisherPMC
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Primary 4‐repeat tauopathies with frontotemporal lobar degeneration (FTLD) like Progressive Supranuclear Palsy (PSP) or Corticobasal Degeneration (CBD) show diverse cellular pathology in various brain regions. Besides shared characteristics of neuronal and oligodendroglial cytoplasmic inclusions of accumulated hyperphosphorylated tau protein (pTau), astrocytes in PSP and CBD contain pathognomonic pTau aggregates — hence, lending the designation tufted astrocytes (TA) or astrocytic plaques (AP), respectively. pTau toxicity is most commonly assigned to neurons, whereas the implications of astrocytic pTau for maintaining neurotransmission within the tripartite synapse of human brains is not well understood. We performed immunofluorescent synapse labeling and automated puncta quantification in the medial frontal gyrus (MFG) and striatal regions from PSP and CBD postmortem samples to capture morphometric synaptic alterations. This approach indicated general synaptic losses of both, excitatory and inhibitory bipartite synapses in the frontal cortex of PSP cases, whereas in CBD lower synapse densities were only related to astrocytic plaques. In contrast to tufted astrocytes in PSP, affected astrocytes in CBD could not preserve synaptic integrity within their spatial domains, when compared to non‐affected internal astrocytes or astrocytes in healthy controls. These findings suggest a pTau pathology‐associated role of astrocytes in maintaining connections within neuronal circuits, considered as the microscopic substrate of cognitive dysfunction in CBD. By contrasting astrocytic‐synaptic associations in both diseases, we hereby highlight astrocytic pTau as an important subject of prospective research and as a potential cellular target for therapeutic approaches in the primary tauopathies PSP and CBD.

          Abstract

          The primary tauopathies progressive supranuclear palsy (PSP) and corticobasal degeneration (CBD) show a diverse pattern of cellular inclusions and neuropathological characteristics. In this article, we show a differentiated analysis of synaptic loss in affected brain regions of pure 4R‐tau PSP and CBD cases. While in CBD frontal cortices synapse loss was mainly associated with the disease‐defining astrocytic plaques, a rather general synaptic depletion was apparent in PSP.

          Related collections

          Most cited references49

          • Record: found
          • Abstract: found
          • Article: not found

          Neurotoxic reactive astrocytes are induced by activated microglia

          A reactive astrocyte subtype termed A1 is induced after injury or disease of the central nervous system and subsequently promotes the death of neurons and oligodendrocytes.
            • Record: found
            • Abstract: found
            • Article: not found

            Clinical diagnosis of progressive supranuclear palsy: The movement disorder society criteria.

            PSP is a neuropathologically defined disease entity. Clinical diagnostic criteria, published in 1996 by the National Institute of Neurological Disorders and Stroke/Society for PSP, have excellent specificity, but their sensitivity is limited for variant PSP syndromes with presentations other than Richardson's syndrome.
              • Record: found
              • Abstract: found
              • Article: not found

              Synapse loss and microglial activation precede tangles in a P301S tauopathy mouse model.

              Filamentous tau inclusions are hallmarks of Alzheimer's disease (AD) and related tauopathies, but earlier pathologies may herald disease onset. To investigate this, we studied wild-type and P301S mutant human tau transgenic (Tg) mice. Filamentous tau lesions developed in P301S Tg mice at 6 months of age, and progressively accumulated in association with striking neuron loss as well as hippocampal and entorhinal cortical atrophy by 9-12 months of age. Remarkably, hippocampal synapse loss and impaired synaptic function were detected in 3 month old P301S Tg mice before fibrillary tau tangles emerged. Prominent microglial activation also preceded tangle formation. Importantly, immunosuppression of young P301S Tg mice with FK506 attenuated tau pathology and increased lifespan, thereby linking neuroinflammation to early progression of tauopathies. Thus, hippocampal synaptic pathology and microgliosis may be the earliest manifestations of neurodegenerative tauopathies, and abrogation of tau-induced microglial activation could retard progression of these disorders.

                Author and article information

                Contributors
                jochen.herms@med.uni-muenchen.de
                Journal
                Brain Pathol
                Brain Pathol
                10.1111/(ISSN)1750-3639
                BPA
                Brain Pathology
                John Wiley and Sons Inc. (Hoboken )
                1015-6305
                1750-3639
                29 December 2020
                July 2021
                : 31
                : 4 ( doiID: 10.1111/bpa.v31.4 )
                : e12914
                Affiliations
                [ 1 ] German Center for Neurodegenerative Diseases (DZNE) e.V., Site Munich Munich Germany
                [ 2 ] Center for Neuropathology and Prion Research University Hospital Munich Ludwig–Maximilians‐University Munich Germany
                [ 3 ] Munich Medical Research School Faculty of Medicine Ludwig‐Maximilians‐University Munich Germany
                [ 4 ] Department of Psychiatry and Psychotherapy University Hospital Munich Ludwig‐Maximilians‐University Munich Germany
                [ 5 ] Munich Cluster of Systems Neurology (SyNergy) Ludwig‐Maximilians‐University Munich Germany
                Author notes
                [*] [* ] Correspondence

                Jochen Herms, Center for Neuropathology and Prion Research, University Hospital Munich, Ludwig–Maximilians‐University, Feodor‐Lynen‐Str. 23, 81377 Munich, Germany.

                Email: jochen.herms@ 123456med.uni-muenchen.de

                Author information
                https://orcid.org/0000-0002-4349-3277
                Article
                BPA12914
                10.1111/bpa.12914
                8412068
                33089580
                8c89cb5d-3e15-4a95-93bf-335b1084fc9a
                © 2020 The Authors. Brain Pathology published by John Wiley & Sons Ltd on behalf of International Society of Neuropathology

                This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.

                History
                : 19 August 2020
                : 12 October 2020
                Page count
                Figures: 5, Tables: 4, Pages: 14, Words: 9891
                Funding
                Funded by: Munich Cluster of Systems Neurology (SyNergy; project ID EXC 2145 / ID 390857198)
                Funded by: Marie Sklodowska‐Curie actions grant
                Award ID: ITN SynDegen (721802)
                Funded by: German Academic Scholarship Foundation
                Categories
                Research Article
                Research Articles
                Custom metadata
                2.0
                July 2021
                Converter:WILEY_ML3GV2_TO_JATSPMC version:6.0.6 mode:remove_FC converted:31.08.2021

                Pathology
                astrocytic plaques,corticobasal degeneration,progressive supranuclear palsy,synapse loss,tauopathy,tufted astrocytes

                Comments

                Comment on this article

                Related Documents Log